Indefinite Delivery Contract 75A50122D00010
Award Date
8/22/22
Last Date to Order
7/31/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services (HHS) awarded an indefinite delivery/indefinite quantity (IDIQ) contract to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization, to provide nonclinical laboratory services for the development and testing of medical countermeasures against chemical threats. The $45 million, single-award IDIQ contract has a period of performance through July 2025. The contract scope covers two groups of services: Group A...
This federal Indefinite Delivery Contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Battelle Memorial Institute, a nonprofit research organization. The $100 million IDIQ contract, titled "BARDA Chem and RadNuc Animal Model 2015-2020", aims to develop human-relevant small animal models for studying the effects of chemical warfare agents and support...
This is a single-award indefinite delivery contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Battelle Memorial Institute, a nonprofit research and development organization. The $90 million IDIQ contract, which runs through July 2025, is for the development of animal models and medical countermeasures related to chemical, biological, radiological, and nuclear threats. Under...
This indefinite delivery contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a component of the U.S. Department of Health and Human Services (HHS), to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $45 million single-award IDC has a period of performance through July 31, 2025 and is for the development of animal models to evaluate the efficacy of medical countermeasures (MCMs)...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $146.3 million single-award Indefinite Delivery Contract (IDC) to the UK Health Security Agency (formerly Public Health England) to provide preclinical services in support of the development of medical countermeasures against chemical, biological, radiological, and nuclear threats. The contract includes task areas for small animal models, non-human primate models, animal replacement and non-traditional animal models,...
The federal contract IDV award W911SR22D0009 was issued by the Joint Program Executive Office for Chemical and Biological Defense, a Defense agency, to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc. The single-award Indefinite Delivery Contract has a ceiling value of $249,006,382.00 and is for the acquisition of FDA-approved products supporting chemical and biological defense programs. Associated task orders under the IDC advance the development and testing of a...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract (IDC) valued at $146,300,000 to The Administrators of the Tulane Educational Fund, doing business as Tulane University. The contract covers a 7-year ordering period and aims to provide preclinical research support services to facilitate the development of medical countermeasures, including animal studies,...
The Indefinite Delivery Contract (IDC) 75N93024D00028 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Tennessee, a non-profit educational institution. The $146.3M contract has an ordering period ending in July 2031 and covers the development and use of animal and animal replacement models to evaluate candidate countermeasures (e.g., therapeutics, vaccines,...
The federal contract IDV award provides indefinite delivery of nonclinical biological services to the Department of Health and Human Services (HHS), specifically the Office of the Assistant Secretary for Preparedness and Response (ASPR). The purpose is to establish a network of Good Laboratory Practices (GLP) facilities capable of conducting animal testing and other analytical services to support the development of medical countermeasures against chemical, biological, radiological, and nuclear...
The federal contract IDV award, valued at up to $146.3 million over a 7-year ordering period, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the Ministry of Defence (D S T L) of the United Kingdom. The contract aims to provide a broad range of animal and animal replacement models to evaluate the efficacy of candidate countermeasures, including vaccines, therapeutics, and diagnostics, against infectious agents under NIAID's purview. This includes models for RNA...